Five relatively small, retrospective studies [26], [28]–[30] have provided evidence that PTEN status is associated with objective responses in cetuximab-treated mCRC patients suggesting that PTEN-positive tumours tend to have a better outcome than negative ones; however, another study failed to confirm this observation [21]. Here, PTEN is linked to neoplasm.